Andrew Whelan, CEO of BioElectronics, said: “This is significant news for BioElectronics. We were already seeing strong success with London drugs in Western Canada and we have recently completed a very successful test with Zeller’s Pharmacies.
“The addition of these new chains, which give us almost Canada-wide coverage, should increase our sales levels further. We are very encouraged by our international sales growth, not only within Canada, but also within the EU.”